Houvast, Ruben D. http://orcid.org/0000-0002-8813-0330
van Duijvenvoorde, Maurice
Chua, JiaXin
Vankemmelbeke, Mireille
Durrant, Lindy G.
Inderson, Akin
van Hooft, Jeanin E.
Mieog, J. Sven D.
Bonsing, Bert A.
Sier, Cornelis F. M.
Crobach, A. Stijn L. P.
Vahrmeijer, Alexander L.
Kuppen, Peter J. K.
Article History
Accepted: 5 December 2022
First Online: 19 January 2023
Declarations
:
: No external funding was obtained for this study.
: Lindy G. Durrant is CEO and CSO of Scancell Ltd and has an ownership interest in the company. JiaXin Chua and Mireille Vankemmelbeke are employed by Scancell Ltd. Ruben D. Houvast, Maurice van Duijvenvoorde, Akin Inderson, Jeanin E. van Hooft, J. Sven D. Mieog, Bert A. Bonsing, Cornelis F.M. Sier, A. Stijn L.P. Crobach, Alexander L. Vahrmeijer and Peter J.K. Kuppen declare no conflicts of interest.
: The study protocol was approved by the Gastroenterology Biobank Review Committee (protocol reference: 2020-16) and local Medical Ethical Review Committee (protocol reference: B20.052). The research was conducted in accordance with the Dutch code of conduct for responsible use of human tissue in medical research. Tissue specimens and clinicopathological data were used anonymized and in compliance with the Declaration of Helsinki (1964).
: The need for informed consent was waived by the local Medical Ethical Review Committee.
: Not applicable.
: The data presented in this study are available upon reasonable request from the corresponding author.
: RDH and MvD were responsible for conceptualization, methodology, formal analysis and visualization. RDH wrote the original draft of the manuscript. All remaining authors contributed to reviewing and editing of the manuscript. PJKK was responsible for supervision. All authors read and approved the final version of the manuscript.